Cargando…

Neurotrophic Treatment Initiated During Early Postnatal Development Prevents the Alzheimer-Like Behavior and Synaptic Dysfunction

BACKGROUND: Alzheimer’s disease (AD) is a progressive neurodegenerative disorder characterized by impairments in synaptic plasticity and cognitive performance. Cognitive dysfunction and loss of neuronal plasticity are known to begin decades before the clinical diagnosis of the disease. The important...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wei, Wei, Liu, Yinghua, Dai, Chun-Ling, Baazaoui, Narjes, Tung, Yunn Chyn, Liu, Fei, Iqbal, Khalid
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8385525/ https://www.ncbi.nlm.nih.gov/pubmed/34057082 http://dx.doi.org/10.3233/JAD-201599

Ejemplares similares

Prenatal to early postnatal neurotrophic treatment prevents Alzheimer-like behavior and pathology in mice
por: Wei, Wei, et al.
Publicado: (2020)

A Novel Therapeutic Approach to Treat Alzheimer’s Disease by Neurotrophic Support During the Period of Synaptic Compensation
por: Baazaoui, Narjes, et al.
Publicado: (2018)

Prevention of dendritic and synaptic deficits and cognitive impairment with a neurotrophic compound
por: Baazaoui, Narjes, et al.
Publicado: (2017)

Inhibition of AMD-Like Pathology With a Neurotrophic Compound in Aged Rats and 3xTg-AD Mice
por: Liu, Yinghua, et al.
Publicado: (2019)

Alzheimer’s Disease: Challenges and a Therapeutic Opportunity to Treat It with a Neurotrophic Compound
por: Baazaoui, Narjes, et al.
Publicado: (2022)

Tau passive immunization blocks seeding and spread of Alzheimer hyperphosphorylated Tau-induced pathology in 3 × Tg-AD mice
por: Dai, Chun-ling, et al.
Publicado: (2018)

Tau passive immunization inhibits not only tau but also Aβ pathology
por: Dai, Chun-ling, et al.
Publicado: (2017)

Involvement of Activation of Asparaginyl Endopeptidase in Tau Hyperphosphorylation in Repetitive Mild Traumatic Brain Injury
por: Hu, Wen, et al.
Publicado: (2018)

Neurotrophic factor small-molecule mimetics mediated neuroregeneration and synaptic repair: emerging therapeutic modality for Alzheimer’s disease
por: Kazim, Syed Faraz, et al.
Publicado: (2016)

Pathological Tau From Alzheimer’s Brain Induces Site-Specific Hyperphosphorylation and SDS- and Reducing Agent-Resistant Aggregation of Tau in vivo
por: Miao, Jin, et al.
Publicado: (2019)

Alzheimer’s disease brain contains tau fractions with differential prion-like activities
por: Li, Longfei, et al.
Publicado: (2021)

Dephosphorylation Passivates the Seeding Activity of Oligomeric Tau Derived From Alzheimer’s Brain
por: Wu, Ruozhen, et al.
Publicado: (2021)

Tau antibody 77G7 targeting microtubule binding domain suppresses proteopathic tau to seed tau aggregation
por: Li, Longfei, et al.
Publicado: (2022)

Two simple assays for assessing the seeding activity of proteopathic tau
por: Liu, Fei, et al.
Publicado: (2023)

Tau seeding activity in various regions of down syndrome brain assessed by two novel assays
por: Jin, Nana, et al.
Publicado: (2022)

Role of Aβ in Alzheimer’s-related synaptic dysfunction
por: Zhang, Huiqin, et al.
Publicado: (2022)

The role of pathological tau in synaptic dysfunction in Alzheimer’s diseases
por: Wu, Moxin, et al.
Publicado: (2021)

Alzheimer's disease: synaptic dysfunction and Aβ
por: Shankar, Ganesh M, et al.
Publicado: (2009)

Oxidative Stress, Synaptic Dysfunction, and Alzheimer’s Disease
por: Tönnies, Eric, et al.
Publicado: (2017)

Proteomic Profile of Mouse Brain Aging Contributions to Mitochondrial Dysfunction, DNA Oxidative Damage, Loss of Neurotrophic Factor, and Synaptic and Ribosomal Proteins
por: Li, Yingchao, et al.
Publicado: (2020)

Early neurotrophic pharmacotherapy rescues developmental delay and Alzheimer’s-like memory deficits in the Ts65Dn mouse model of Down syndrome
por: Kazim, Syed Faraz, et al.
Publicado: (2017)

Dysfunctional Mitochondrial Bioenergetics and Synaptic Degeneration in Alzheimer Disease
por: Tang, Jason, et al.
Publicado: (2019)

Intracellular Trafficking Mechanisms of Synaptic Dysfunction in Alzheimer’s Disease
por: Perdigão, Catarina, et al.
Publicado: (2020)

Amyloidogenesis and Neurotrophic Dysfunction in Alzheimer’s Disease: Do They have a Common Regulating Pathway?
por: Jiao, Fengjuan, et al.
Publicado: (2022)

Synaptic dysfunction and oxidative stress in Alzheimer’s disease: Emerging mechanisms
por: Forero, D A, et al.
Publicado: (2006)

Oligomeric Aβ-induced synaptic dysfunction in Alzheimer’s disease
por: Tu, Shichun, et al.
Publicado: (2014)

Cortical Circuitry and Synaptic Dysfunctions in Alzheimer's Disease and Other Dementias
por: Ranieri, Federico, et al.
Publicado: (2021)

Microbiota in neuroinflammation and synaptic dysfunction: a focus on Alzheimer’s disease
por: Bairamian, Diane, et al.
Publicado: (2022)

Neurogranin as a Reliable Biomarker for Synaptic Dysfunction in Alzheimer’s Disease
por: Agnello, Luisa, et al.
Publicado: (2021)

Cerebrospinal fluid biomarker panel for synaptic dysfunction in Alzheimer's disease
por: Nilsson, Johanna, et al.
Publicado: (2021)

Does proteopathic tau propagate trans-synaptically in the brain?
por: Hu, Wen, et al.
Publicado: (2022)

Neurotrophic delivery in Alzheimer’s-model mice
por: Konofagou, Elisa, et al.
Publicado: (2015)

Gut Microbiota and Immunotherapy for Alzheimer’s Disease
por: Dai, Chun-Ling, et al.
Publicado: (2022)

Building better brains: the pleiotropic function of neurotrophic factors in postnatal cerebellar development
por: Boxy, Pia, et al.
Publicado: (2023)

A synapsin Ⅰ cleavage fragment contributes to synaptic dysfunction in Alzheimer's disease
por: Meng, Lanxia, et al.
Publicado: (2022)

Neuroprotective, Anti-Amyloidogenic and Neurotrophic Effects of Apigenin in an Alzheimer’s Disease Mouse Model
por: Zhao, Le, et al.
Publicado: (2013)

CSF GAP-43 as a biomarker of synaptic dysfunction is associated with tau pathology in Alzheimer’s disease
por: Qiang, Qiang, et al.
Publicado: (2022)

Cholesterol in the Pathogenesis of Alzheimer’s, Parkinson’s Diseases and Autism: Link to Synaptic Dysfunction
por: Petrov, A. M., et al.
Publicado: (2017)

Circuitry and Synaptic Dysfunction in Alzheimer's Disease: A New Tau Hypothesis
por: Mondragón-Rodríguez, Siddhartha, et al.
Publicado: (2020)

Neurogranin and Neuronal Pentraxin Receptor as Synaptic Dysfunction Biomarkers in Alzheimer’s Disease
por: Dulewicz, Maciej, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_te4phvsnhq054jvchnjv25g9gi